Erratum: Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients

, Frontiers Production Office

doi:10.3389/fnagi.2023.1176468

ERRATUM article

Front. Aging Neurosci. , 09 March 2023

Sec. Alzheimer's Disease and Related Dementias

Volume 15 - 2023 | https://doi.org/10.3389/fnagi.2023.1176468

Erratum: Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients

This article is an erratum on:

Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients
1. Read original article

$\nFrontiers Production Office$ Frontiers Production Office^*

Frontiers Media SA, Lausanne, Switzerland

An Erratum on
Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients

by Pautex, S., Bianchi, F., Daali, Y., Augsburger, M., de Saussure, C., Wampfler, J., Curtin, F., Desmeules, J. and Broers, B. (2022). Front. Aging Neurosci. 14:957665. doi: 10.3389/fnagi.2022.957665

An omission to the funding section of the original article was made in error. The following sentence has been added: “Open access funding was provided by the University of Geneva.”

The original article has been updated.

Keywords: cannabinoids, dementia, symptoms relief, long-term care, medical cannabis

Citation: Frontiers Production Office (2023) Erratum: Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients. Front. Aging Neurosci. 15:1176468. doi: 10.3389/fnagi.2023.1176468

Received: 28 February 2023; Accepted: 28 February 2023;
Published: 09 March 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Erratum: Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients

94% of researchers rate our articles as excellent or good

94% of researchers rate our articles as excellent or good